Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vaccine
Biotech
Merck bags options on Evaxion's AI-designed vaccine candidates
Merck dangled more than $1 billion in milestones for options on preclinical prospects against gonorrhea and an undisclosed infectious agent.
Nick Paul Taylor
Sep 26, 2024 7:30am
Moderna mpox vaccine passes muster in monkeys
Sep 4, 2024 11:00am
Sanofi pays $175M for J&J's late-phase E. coli vaccine
Oct 3, 2023 7:32am
Arcturus sa-mRNA COVID boosters induce immune response in ph. 2
Sep 19, 2023 11:40am
Variant vulnerability vanquishes Bavarian Nordic's COVID vaccine
Sep 1, 2023 5:39am
FDA delays decision on Valneva's chikungunya vaccine by 3 months
Aug 14, 2023 6:00am